Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Link?
Hi volume here today. Hopefully price action stays positive and we get some good news soon!
GLTA
Murocman
Over $50M worth of volume! There ought to be some SC-13G forms coming because it ain’t retail throwing around that kind of cash.
GLTA,
Murocman
Big volume yet no news. Somebody thinks they know something good. Hopefully we find out soon!
GLTA,
Murocman
Any idea on when knee data will be out? Hard to find much information on the trial.
Murocman
Very Nice! If the company doesn't PR this right away, one should be able to find the size of the contract in the Federal Register Online.
GLTA,
Murocman
This presentation will occur overnight U.S. time. Given that, I would not be surprised to see a PR late today or before the market opens tomorrow.
GLTA,
Murocman
There has certainly already been lots of institutional activity today. 55+ Million shares aren't moving due to retail activity.
GLTA,
Murocman
I'd agree. Probably gap up and then dip at the 100% up point from the Friday close. Am expecting a close in the $3-5 range.
Murocman
Robotic Surgery Market estimated to grow to $6B by 2020 according
to AlliedMarketResearch.com
GLTA,
Murocman
MACI is already approved and generating revenue so is by definition more valuable at the moment.
That said, the heart failure market is large and there would likely be more profit margin and virtually no competition so is probably is the bigger revenue contributor in the long run IMO.
GLTU,
Murocman
Agreed. Volume started off kind of slow but filled in nicely and the price stayed up!
Murocman
Nice start to the day as far as price movement. Would like to see some more volume to back it up, though.
Murocman
It's been expected for some time. Delays do not usually signal good news. Earlier data was good but not willing to bank on that. Watching at this point.
GLTU,
Murocman
Very Very nice news today!
The $16M won't cover all of Phase III but it's certainly a nice chunk of non-dilutive money and a big endorsement for the company!
Murocman
Funding and potential dilution for Phase III is my only concern at this point. Everything else looks great!
Murocman
Thank you for the summary! Any discussion of how they are paying for Phase III?
Murocman
Thank you very much for the comprehensive and detailed response! That helps a lot.
Murocman
Sorry..that should be idea not Leda in previous post. Dumb Apple auto word suggest!
Murocman
What lends to the Leda that this trial will be more successful than the last one?
It seems that there is a lot of risk here given past history from January 2017.
GLTA
Murocman
Developing Elk Creek is one thing but whether or not shareholders profit is another question, which is why the share price is only at 50 cents. Still a lot of uncertainty on how this mine is financed. Until that becomes clear the share price will languish IMO.
Murocman
Look for FY earnings mid-late September based on history and they have 90 days to file their FY report with the SEC.
GLTA,
Murocman
Nice Exposure
http://www.newsmax.com/Health-News/APFN-US-MED-New-EpiPen-Rival/2017/06/16/id/796429/
GLTA,
Muroman
I guess we'll have to agree to disagree. My education from Investors Daily says otherwise. Nice bounce off the 50 day yesterday and volume looking decent today.
All this in the context that FDA news is the driver here, not technicals. My point being that if FDA does approve, the chart is set up nicely to support the price advance.
Murocman
Let's see how it closes.
Murocman
Classic cup and handle chart pattern formed. Very bullish from a technical perspective.
GLTA,
Murocman
PIRS$. Huge volume and nice move on no news today.
Murocman
Huge volume, solid move, no news and no posts! What gives?
Murocman
Thought we would see earnings today. Now expecting tomorrow or Thursday.
GLTA,
Murocman
Volume was also on the lower side today so much easier for the share price to be manipulated.
Murocman
When and based on what catalyst(s)
TIA
Murocman
TASE closed on Monday for start of Passover. Unless data comes today (TASE open) it will likely be Tuesday at the earliest.
Murocman
Monumental week coming up. Assuming the data is good, it will be very interesting to see if this trades into a higher range? It should, but it seems it's hard in many cases for small cap Israeli biotech's to get the respect of the market.
GLTA,
Murocman
Very nice! I have to say this price action is a pleasant surprise. I was expecting dilution for additional cash given Phase III imminent and only hat $10M at the end of last quarter. Maybe they found a partner or the like?
Murocman
Some nice volume and price movement out of the gate this morning.
Murocman
VCEL...nice volume with good price movement out of the gate this morning on no news.
Murocman
I'd agree with that. Once they hit 3 quarters of sustained, growing earnings, it won't be looked at as a fluke. The street will take notice, institutions will start following, accumulating and promoting. It won't take too long to find out as next earnings should hit around May 10th.
Murocman
Saw something about an "Oprah Rumor" gaining steam on another IHub board. Does that ring any bells with anyone?
Murocman
Do you have a link, source or background?
Certainly a lot of volume the last couple of days,
Murocman
Agreed. With the US Govt making noises about strengthening ties with China and increased infrastructure spending, I expect the shipping sector to strengthen further. At some point this will pop hard when the street realizes it the "best in class" as far as shipping sector investments. Their next earnings report can't come quick enough!
Murocman